Send feedback

DAB2 p.Asp164Glu

c.492C>A · rs573228910 · VCV3079894

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.9413 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00112%, sas)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense0.9413likely pathogenic · top 9% in DAB2
REVEL0.312indeterminate
SaProtLLR -7.10tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.7GERP -1.4, phastCons 1
Regional constrainto/e 1.01unconstrained · MANE · 15 kb · p 0.83 · regional, not allelic
Overall
CADD22.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00112% South Asian · 1/89,124 alleles
Filtering AF 0.000125% ClinGen BA1/BS1 input FAF95, joint · FAF99 9.1e-05%
Overall 0.000376% 6/1,596,198 alleles · very rare
Ancestry group Frequency 1 in
South Asiangrpmax 0.00112% 89,124
European (non-Finnish) 0.000427% 233,952

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DAB2
Protein
p.Asp164Glu
Coding
c.492C>A
MANE Select
NM_001343
dbSNP
rs573228910
Type
single nucleotide variant
Location
chr5:39389903 (GRCh38)
Gene constraint
LOEUF 0.479 · pLI 0.99 (gnomAD)
Structure
AlphaFold pLDDT 54.33 · 3 PDB
Residue 164
the pid domain; an α-helix
Full DAB2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dab2-p-asp164glu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown